Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease

Author(s): Zhang L, Le W, Xie W, Dani JA

Abstract

The nuclear receptor related 1 (Nurr1) transcription factor contributes to the development and maintenance of dopamine (DA) neurons in the brain. We found that heterozygous Nurr1 knockout (Nurr1 +/−) influenced the age-dependent decline in the number of DA neurons and influenced DA signaling. We examined the DA marker, tyrosine hydroxylase, using immunohistochemistry, and we measured DA signaling using fast-scan cyclic voltammetry in 3 age groups of wild-type (Nurr1 +/+) and mutant (Nurr1 +/−) mice: 3–6, 9–12, and 15–23 mo old. Prior to significant loss of DA neurons and to the onset of parkinsonian symptoms, young Nurr1 +/− mice (3–6 mo) exhibited a decrease in peak evoked DA release that was partially countered by a decrease in the rate of DA reuptake. As peak evoked DA release declined with age for both the wild-type and Nurr1 +/− mice, both genotypes manifested decreased DA reuptake. As the DA release fell further with age, decreased DA reuptake eventually could not adequately compensate the Nurr1 +/− mice. The results indicated that Nurr1 deficiency led to impaired DA release even before significant DA neuron loss.

Similar Articles

Etiology of Parkinson's disease: Genetics and environment revisited

Author(s): Steece-Collier K, Maries E, Kordower JH

Dopamine neuron agenesis in Nurr1-deficient mice

Author(s): Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, et al.

Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neuron

Author(s): Castillo SO, Baffi JS, Palkovits M, Goldstein DS, Kopin IJ, et al.

Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells

Author(s): Hermanson E, Joseph B, Castro D, Lindqvist E, Aarnisalo P, et al.

Transcription factor Nurr1 maintains fiber integrity and nuclearencoded mitochondrial gene expression in dopamine neurons

Author(s): Kadkhodaei B, Alvarsson A, Alvarsson A, Schintu N, Ramskold D, et al.

NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection

Author(s): Volakakis N, Kadkhodaei B, Joodmardi E, Wallis K, Panman L, et al.

A-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons

Author(s): Decressac M, Kadkhodaei B, Mattsson B, Laguna A, Perlmann T, et al.

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson’s disease

Author(s): Oh S, Chang M, Song J, Rhee Y, Joe E, et al.

Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease

Author(s): Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, et al.

Familial Parkinson's disease: a hint to elucidate the mechanisms of nigral degeneration

Author(s): Hattori N, Kobayashi H, Sasaki-Hatano Y, Sato K, Mizuno Y

Mutations in NR4A2 associated with familial Parkinson disease

Author(s): Le WD, Xu P, Jankovic J, Jiang H, Appel SH, et al.

Translated mutation in the Nurr1 gene as a cause for Parkinson's disease

Author(s): Grimes DA, Han F, Panisset M, Racacho L, Xiao F, et al.

Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra

Author(s): Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH

NURR1 mutations in cases of schizophrenia and manic-depressive disorder

Author(s): BuervenichS, Carmine A, Arvidsson M, Xiang F, ZhangZ, et al.

Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism

Author(s): Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ

Regulation of GTP cyclohydrolase I expression by orphan receptor Nurr1 in cell culture and in vivo

Author(s): Gil M, McKinney C, Lee MK, Eells JB, Phyillaier MA, et al.

Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons

Author(s): Kadkhodaei B, Ito T, Joodmardi E,Mattsson B, Rouillard C, et al.

Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice

Author(s): Imam SZ, Jankovic J, Ali SF, Skinner JT, Xie W, et al.

Aging of the striatum: mechanisms and interventions

Author(s): Umegaki H, Roth GS, Ingram DK

Structure and function of the Nur77 subfamily, a unique class of hormone nuclear receptors

Author(s): Eells JB,Witta J,Otridge JB, Zuffova E, Nikodem VM

Age-dependent dopaminergic dysfunction in Nurr1 knockout mice

Author(s): Iang C, Wan X, He Y, Pan T, Jankovic J, et al.

Chronic Toxoplasma gondii in Nurr1-null heterozygous mice exacerbates elevated

Author(s): EellJB, Varela-Stokes A, Guo-Ross SX, Kummari E, Smith HM, et al.

Parkinson disease in twins: an etiologic study

Author(s): Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, et al.

No evidence for heritability of Parkinson disease in Swedish twins

Author(s): Wirdefeldt K, Gatz M, Schalling M, Pedersen NL

Heritability of Parkinson disease in Swedish twins: a longitudinal study

Author(s): Wirdefeldt K, Gatz M, Reynolds CA, Prescott CA, Pedersen NL

Decreased ethanol preferences and wheel running in Nurr1-deficient mice

Author(s): Werme M, HermansonE, Carmine A, Buervenich S, Zetterstrom RH, et al.

Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency

Author(s): VuillermotS, JoodmardiE, Perlmann T, Ove Ögren S,FeldonJ, et al.

Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain

Author(s): DiSalvio M, Di Giovannantonio LG, OmodeiD, AcamporaD, SimeoneA